This company has been marked as potentially delisted and may not be actively trading. NASDAQ:GTXI GTX (GTXI) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisCompetitorsHeadlinesTrendsBuy This Stock About GTX Stock (NASDAQ:GTXI) 30 days 90 days 365 days Advanced Chart Get GTX alerts:Sign Up Key Stats Today's Range$0.53▼$0.5350-Day Range$1.20▼$7.2052-Week Range$0.74▼$25.60VolumeN/AAverage Volume390,540 shsMarket Capitalization$12.66 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewGTx, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of medicines for the treatment of stress urinary incontinence (SUI) and prostate cancer. It develops selective androgen receptor modulators (SARMs) for the treatment of breast cancer, SUI, and Duchenne muscular dystrophy; and selective androgen receptor degraders to treat progressive castration-resistant prostate cancer. The company's SARM product candidate is the enobosarm GTx-024, a Phase II proof-of-concept clinical trial for patients with androgen receptor (AR) positive triple-negative breast cancer; and estrogen receptor positive and AR positive advanced breast cancer, as well as postmenopausal women with SUI. GTx, Inc. was founded in 1997 and is headquartered in Memphis, Tennessee.Read More… Receive GTXI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for GTX and its competitors with MarketBeat's FREE daily newsletter. Email Address GTXI Stock News HeadlinesGTX 1660 Ti vs RTX 2060 SUPER vs RTX 3060 Ti vs RTX 4060 Ti - Test in 8 GamesMay 27 at 5:26 PM | msn.comGTX 980 Ti vs GTX 1080 Ti vs RTX 2080 Ti Test in 8 GamesMay 26 at 9:38 PM | msn.comElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believes will be Elon’s greatest invention ever… Yes, even bigger than Tesla or SpaceX.May 28, 2025 | Brownstone Research (Ad)GTX 1660 Ti vs GTX 1070 Test in 8 GamesMay 26 at 9:38 PM | msn.comASUS GTX 1070 Ti ROG Strix Review - FAST BUT £500?May 21, 2025 | msn.comMeiraGTx (MGTX) Gains RMAT Designation for Parkinson's TreatmentMay 9, 2025 | gurufocus.comGTX groundbreakings raise concerns over electioneeringMay 9, 2025 | msn.comGarrett Motion Inc (GTX) Q1 2025 Earnings Call Highlights: Navigating Challenges with Strategic ...May 2, 2025 | finance.yahoo.comSee More Headlines GTXI Stock Analysis - Frequently Asked Questions How were GTX's earnings last quarter? GTx, Inc. (NASDAQ:GTXI) issued its quarterly earnings data on Thursday, November, 15th. The biopharmaceutical company reported ($0.39) EPS for the quarter, missing the consensus estimate of ($0.30) by $0.09. What other stocks do shareholders of GTX own? Based on aggregate information from My MarketBeat watchlists, some other companies that GTX investors own include Corbus Pharmaceuticals (CRBP), Synergy Pharmaceuticals (SGYP), Novavax (NVAX), SELLAS Life Sciences Group (SLS), Verastem (VSTM), Bristol-Myers Squibb (BMY) and Catalyst Pharmaceuticals (CPRX). Company Calendar Last Earnings11/15/2018Today5/28/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical Preparations Sub-IndustryBiotechnology Current SymbolNASDAQ:GTXI CIK1260990 Webwww.gtxinc.com Phone901-523-9700FaxN/AEmployees21Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($1.65) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$38.42 million Net MarginsN/A Pretax MarginN/A Return on Equity-104.19% Return on Assets-86.42% Debt Debt-to-Equity RatioN/A Current Ratio12.39 Quick Ratio12.39 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$1.09 per share Price / Book0.48Miscellaneous Outstanding Shares24,050,000Free FloatN/AMarket Cap$12.66 million OptionableNot Optionable Beta2.22 Ten Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free Report This page (NASDAQ:GTXI) was last updated on 5/28/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredTrump Predicts Dollar DownfallREAD THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... ...Augusta Precious Metals | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | Sponsored“You all just got a lot richer”Trump Knows What He’s Doing. When the president says he’s going to let RFK “go wild” … and Big Pharma crash...Brownstone Research | SponsoredThe “supermetal” that could power AIWhile the headlines focus on AI models and chip speed, Elon Musk is investing in the material side of the stor...True Market Insiders | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GTx, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share GTX With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.